We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

FAPON

Fapon is a global IVD raw materials & one-stop solutions company offering 700+ reagent raw materials for the applicat... read more Featured Products: More products

Download Mobile App





Fapon Biotech Presents Latest IVD Innovations at Medlab Middle East 2023

By LabMedica International staff writers
Posted on 09 Feb 2023
Print article
Image: IVD raw materials and reagent services featured at Medlab Middle East 2023 (Photo courtesy of Fapon)
Image: IVD raw materials and reagent services featured at Medlab Middle East 2023 (Photo courtesy of Fapon)

Fapon Biotech (Guangdong, China) is presenting its latest IVD innovations at the 22nd edition of Medlab Middle East Congress taking place live, in-person from 6-9 February 2023.

As a leading supplier of IVD raw materials and customized solutions, Fapon has continuously developed and optimized its product portfolio to accelerate disease testing for downstream diagnostic companies. Fapon provides over 1300 antibodies, antigens, enzymes, blockers, and more on different technology platforms of chemiluminescence, ELISA, rapid test, immunoturbidimetry, PCR and NGS. At Medlab Middle East 2023, Fapon is introducing its wide range of raw materials and reagent services, such as cardiac marker, tumor marker, respiratory disease, inflammatory marker, tropical disease, infectious disease, drug of abuse, polymerase & mix, reverse transcriptase & mix, LAMP polymerase, PCR miscellaneous, and many more.

Fapon is also presenting its self-developed series of high-performance chemiluminescence immunoassay analyzers that are open and fully customizable. This includes Shine i1000, the smallest fully automatic chemiluminescence immunoassay analyzer, as well as the Shine i2000 compact yet robust and large capacity IVDR certified analyzer which is compatible with AE, AP, HRP, ABEI protocols. In addition, Fapon is showcasing the P810 real-time PCR analyzer and the iCatch2000 rapid molecular point-of-care analyzer. Equipped with Fapon’s core raw materials and reagent services, these instruments provide a one-stop solution for chemiluminescence immunoassay and ultra-fast PCR, respectively.

Related Links:
Fapon Biotech

Gold Member
Veterinary Hematology Analyzer
Exigo H400
Verification Panels for Assay Development & QC
Seroconversion Panels
New
FOB+Transferrin+Calprotectin+Lactoferrin Test
CerTest FOB+Transferrin+Calprotectin+Lactoferrin Combo Test
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: Karius Focus BAL is designed to quickly identify the etiology of lung infections and improve diagnostic yield over standard of care testing (Photo courtesy of Karius)

Microbial Cell-Free DNA Test Accurately Identifies Pathogens Causing Pneumonia and Other Lung Infections

Bronchoalveolar lavage (BAL) is a commonly used procedure for diagnosing lung infections, especially in immunocompromised patients. However, standard tests often fail to pinpoint the exact pathogen, leading... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.